+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Enzyme Inhibitor Global Market Report 2024

  • PDF Icon

    Report

  • 200 Pages
  • December 2023
  • Region: Global
  • The Business Research Company
  • ID: 5767350

Quick Summary:

In an increasingly complex and rapidly changing global healthcare landscape, being informed about key industry developments is not simply a luxury, but a necessity. The enzyme inhibitor market represents a crucial sphere within this landscape. Spanning various areas from pharmaceuticals and biotechnology to food and beverage, enzyme inhibitors are stand-out players in disease treatments such as chemotherapy, cardiovascular treatments, and antibiotics.

From understanding the impact of strategic partnerships and emerging trends, to assessing the competitive landscape of the industry, our enzyme inhibitor market research report provides detailed insights and complex data in a navigable, easy-to-understand format. The rise in the incidence of diseases, including various forms of cancer, drives home the importance of this area of the market. Investing in our enzyme inhibitor market report will significantly enhance your grasp of this multi-faceted industry and help you navigate its future trajectory. Absorb comprehensive industry views, make informed decisions, and confidently seize opportunities for growth with this indispensable resource.

Enzyme inhibitor refers to a chemical that inhibits an enzyme's activity. Enzymes participate in a variety of cell processes, including cell signaling, growth, and division, as well as accelerating chemical reactions in the body. Enzymes help to speed up chemical reactions in the body and take part in many cell functions, including cell signaling, growth, and division.

The main types of enzyme inhibitors are proton pump inhibitors (PPIs), protease inhibitors, reverse transcriptase inhibitors, aromatase inhibitors, kinase inhibitors, neuraminidase inhibitors, statins, and other types. Proton pump inhibitors refer to medicines that work by decreasing the amount of stomach acid made by glands in the lining of the stomach. The various disease indications include chronic obstructive pulmonary disorders, cardiovascular disease, gastrointestinal disorders, arthritis, inflammatory diseases, and others. The enzyme inhibitors are applicable in chemotherapy, antibiotics, pesticides, cardiovascular treatments, and others and are used in pharmaceuticals, biotechnology, food and beverage, and other end users.

The enzyme inhibitors market research report is one of a series of new reports that provides enzyme inhibitors market statistics, including enzyme inhibitors industry global market size, regional shares, competitors with an enzyme inhibitors market share, detailed enzyme inhibitors market segments, market trends and opportunities, and any further data you may need to thrive in the enzyme inhibitors industry. This enzyme inhibitors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The enzyme inhibitor market size has grown steadily in recent years. It will grow from $180.38 billion in 2023 to $186.04 billion in 2024 at a compound annual growth rate (CAGR) of 3.1%. The growth in the historic period can be attributed to increased demand for enzyme inhibitors in the treatment of various diseases, advancements in drug discovery and development, growing prevalence of chronic diseases, increased geriatric population, rising awareness about the benefits of enzyme inhibitors.

The enzyme inhibitor market size is expected to see steady growth in the next few years. It will grow to $216.75 billion in 2028 at a compound annual growth rate (CAGR) of 3.9%. The growth in the forecast period can be attributed to growing investment in research and development activities, increasing demand for personalized medicine, rising incidence of chronic diseases in emerging markets, growing demand for enzyme inhibitors in the treatment of cancer, expansion of applications in rare and genetic diseases. Major trends in the forecast period include development of reversible and irreversible enzyme inhibitors, exploration of natural products as sources of enzyme inhibitors, integration of computational methods in enzyme inhibitor discovery, emphasis on personalized dosing and treatment regimens, expansion of enzyme inhibitor applications in oncology and neurodegenerative diseases.

The rise in the incidence of diseases including cancer is expected to propel the growth of the enzyme inhibitor market going forward. Enzymes, such as telomerase, which is active in most tumor cells, are utilized to cure cancers, including leukemia, and also keep healthy adult cells from becoming cancerous. For instance, in January 2022, according to the American Cancer Society, a US-based non-profit healthcare group dedicated to cancer elimination, on average in the US, 1,670 individuals are going to die from cancer every day in 2022, with 1.9 million cases being diagnosed and 609,360 fatalities. Therefore, the rise in the incidence of diseases such as cancer is driving the demand for the enzyme inhibitor market growth.

The increasing demand for personalized medicine is expected to propel the growth of the enzyme inhibitor market in the coming years. Personalized medicine, additionally referred to as precision medicine, is a health care and treatment method that considers each person's specific diversity in DNA, surroundings, and lifestyle. Enzyme inhibitors are a valuable tool in personalized medicine because they can be adjusted to particular individuals or disease subtypes and have a wide range of applications in personalized medicine, including focused therapy, precision medicine, diagnostics, and drug discovery. For instance, in 2022, according to the Personalized Medicine Coalition, a US-based nonprofit umbrella association for pharmaceuticals, biotechnology, diagnosis, and information technology firms, as well as healthcare providers and payers, personalized medications contributed to 34% of new drug approvals by the US Food and Drug Administration and had been responsible for at least 25% of approvals in each of the previous eight years. Therefore, the increasing demand for personalized medicine is driving the enzyme inhibitor market.

Strategic partnerships and collaborations have emerged as a key trend gaining popularity in the enzyme inhibitor market. Major companies operating in enzyme inhibitors are focused on strategic partnerships to meet customer demand. For instance, in April 2021, Artios Pharma Limited, a UK-based DNA damage response company that also provides enzyme inhibitors, collaborated with Novartis International AG, a Switzerland-based pharmaceutical corporation, to uncover and verify new generation DDR (DNA Damage Response) targets to advance Novartis' Radioligand Therapies (RLT). This partnership with Novartis will be utilized to find and validate next-generation DDR targets to improve Novartis' radioligand therapies.

Major companies operating in the enzyme inhibitor market are focusing on developing innovative products, such as Sotyktu, to better meet the needs of their existing consumers. Sotyktu is an allosteric tyrosine kinase 2 (TYK2) inhibitor drug intended to inhibit or limit the activity of the TYK2 enzyme by attaching to a location on the enzyme other than its active site. For instance, in September 2022, Bristol-Myers Squibb Company, a US-based pharmaceutical firm, announced the approval of Sotyktu, a selective oral allosteric tyrosine kinase 2 (TYK2) inhibitor that is the first of its kind by the U. S. Food and Drug Administration. Sotyktu is a prescription medication authorized for treating people with moderate-to-severe plaque psoriasis who are not candidates for systemic therapy or phototherapy. 1,2 Sotyktu should not be used in conjunction with other strong immunosuppressants. Sotyktu can serve as the new standard of care for oral therapy for persons with moderate-to-severe plaque psoriasis due to its track record of assisting patients in attaining smoother skin in the POETYK PSO clinical study.

In March 2021, Amgen Inc., a US-based biotechnology company, acquired Rodeo Therapeutics Corporation for a deal amount of $666 million. Through this acquisition, Rodeo is focused on developing first-in-class, orally available modulators of prostaglandin biology that play an important role in tissue regeneration and repair. Rodeo Therapeutics Corporation is a US-based biopharmaceutical company that develops enzyme inhibitors.

Major companies operating in the in the enzyme inhibitor market report are Abbott Laboratories, Amgen Inc., AstraZeneca plc, Bayer AG, F. Hoffmann-La Roche AG, Pfizer Inc., Ranbaxy Laboratories Limited, Takeda Pharmaceutical Company, Merck and Co. Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, Cipla USA Inc., AbbVie Inc., Teva Pharmaceutical Industries Ltd., Janssen Pharmaceuticals, Acellera Ltd., Bioinfogate SL, BioSolveIT GmbH, Dassault Systèmes BIOVIA Corp., ChemAxon Ltd., Cheminformatics Tools and Services LLC, Cresset BioMolecular Discovery Ltd., Dotmatics Limited, Enamine Ltd., Forge Therapeutics Inc., Inte:Ligand GmbH, LeadIT, Molecular Forecaster Inc., Chemical Computing Group Inc., OpenEye Scientific Software Inc.

North America was the largest region in the enzyme inhibitor market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the enzyme inhibitor market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the enzyme inhibitor market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The enzyme inhibitor market consists of sales of competitive, noncompetitive, and uncompetitive inhibitors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified)).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. Enzyme Inhibitor Market Characteristics3. Enzyme Inhibitor Market Trends And Strategies
4. Enzyme Inhibitor Market - Macro Economic Scenario
4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market
5. Global Enzyme Inhibitor Market Size and Growth
5.1. Global Enzyme Inhibitor Market Drivers and Restraints
5.1.1. Drivers Of The Market
5.1.2. Restraints Of The Market
5.2. Global Enzyme Inhibitor Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Enzyme Inhibitor Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Enzyme Inhibitor Market Segmentation
6.1. Global Enzyme Inhibitor Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Proton Pump Inhibitors (PPIs)
Protease Inhibitors
Reverse Transcriptase Inhibitors
Aromatase Inhibitors
Kinase Inhibitors
Neuraminidase Inhibitors
Statins
Other Types
6.2. Global Enzyme Inhibitor Market, Segmentation By Disease Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Chronic Obstructive Pulmonary Disorders
Cardiovascular Disease
Gastrointestinal Disorders
Arthritis
Inflammatory Diseases
Other Disease Indications
6.3. Global Enzyme Inhibitor Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Chemotherapy
Antibiotics
Pesticides
Cardiovascular Treatments
Other Applications
6.4. Global Enzyme Inhibitor Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Pharmaceutical
Biotechnology
Food and Beverage
Other End Users
7. Enzyme Inhibitor Market Regional And Country Analysis
7.1. Global Enzyme Inhibitor Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Enzyme Inhibitor Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Enzyme Inhibitor Market
8.1. Asia-Pacific Enzyme Inhibitor Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Enzyme Inhibitor Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Enzyme Inhibitor Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Enzyme Inhibitor Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Enzyme Inhibitor Market
9.1. China Enzyme Inhibitor Market Overview
9.2. China Enzyme Inhibitor Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Enzyme Inhibitor Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Enzyme Inhibitor Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Enzyme Inhibitor Market
10.1. India Enzyme Inhibitor Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Enzyme Inhibitor Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Enzyme Inhibitor Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Enzyme Inhibitor Market
11.1. Japan Enzyme Inhibitor Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.2. Japan Enzyme Inhibitor Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Enzyme Inhibitor Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Enzyme Inhibitor Market
12.1. Australia Enzyme Inhibitor Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Enzyme Inhibitor Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Enzyme Inhibitor Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Enzyme Inhibitor Market
13.1. Indonesia Enzyme Inhibitor Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Enzyme Inhibitor Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Enzyme Inhibitor Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Enzyme Inhibitor Market
14.1. South Korea Enzyme Inhibitor Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.2. South Korea Enzyme Inhibitor Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Enzyme Inhibitor Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Enzyme Inhibitor Market
15.1. Western Europe Enzyme Inhibitor Market Overview
15.2. Western Europe Enzyme Inhibitor Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Enzyme Inhibitor Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Enzyme Inhibitor Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Enzyme Inhibitor Market
16.1. UK Enzyme Inhibitor Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Enzyme Inhibitor Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Enzyme Inhibitor Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Enzyme Inhibitor Market
17.1. Germany Enzyme Inhibitor Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Enzyme Inhibitor Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Enzyme Inhibitor Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Enzyme Inhibitor Market
18.5. France Enzyme Inhibitor Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.6. France Enzyme Inhibitor Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.7. France Enzyme Inhibitor Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Enzyme Inhibitor Market
19.9. Italy Enzyme Inhibitor Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.10. Italy Enzyme Inhibitor Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.11. Italy Enzyme Inhibitor Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Enzyme Inhibitor Market
20.13. Spain Enzyme Inhibitor Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.14. Spain Enzyme Inhibitor Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.15. Spain Enzyme Inhibitor Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Enzyme Inhibitor Market
21.1. Eastern Europe Enzyme Inhibitor Market Overview
21.2. Eastern Europe Enzyme Inhibitor Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Enzyme Inhibitor Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Enzyme Inhibitor Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Enzyme Inhibitor Market
22.1. Russia Enzyme Inhibitor Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Enzyme Inhibitor Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Enzyme Inhibitor Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Enzyme Inhibitor Market
23.1. North America Enzyme Inhibitor Market Overview
23.2. North America Enzyme Inhibitor Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Enzyme Inhibitor Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Enzyme Inhibitor Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Enzyme Inhibitor Market
24.1. USA Enzyme Inhibitor Market Overview
24.2. USA Enzyme Inhibitor Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Enzyme Inhibitor Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Enzyme Inhibitor Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Enzyme Inhibitor Market
25.1. Canada Enzyme Inhibitor Market Overview
25.2. Canada Enzyme Inhibitor Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Enzyme Inhibitor Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Enzyme Inhibitor Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Enzyme Inhibitor Market
26.1. South America Enzyme Inhibitor Market Overview
26.2. South America Enzyme Inhibitor Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Enzyme Inhibitor Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Enzyme Inhibitor Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Enzyme Inhibitor Market
27.1. Brazil Enzyme Inhibitor Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Enzyme Inhibitor Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Enzyme Inhibitor Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Enzyme Inhibitor Market
28.1. Middle East Enzyme Inhibitor Market Overview
28.2. Middle East Enzyme Inhibitor Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Enzyme Inhibitor Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Enzyme Inhibitor Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Enzyme Inhibitor Market
29.1. Africa Enzyme Inhibitor Market Overview
29.2. Africa Enzyme Inhibitor Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Enzyme Inhibitor Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Enzyme Inhibitor Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Enzyme Inhibitor Market Competitive Landscape And Company Profiles
30.1. Enzyme Inhibitor Market Competitive Landscape
30.2. Enzyme Inhibitor Market Company Profiles
30.2.1. Abbott Laboratories
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Amgen Inc.
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. AstraZeneca plc
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Bayer AG
30.2. 4.1. Overview
30.2. 4.2. Products and Services
30.2. 4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. F. Hoffmann-La Roche AG
30.2. 5.1. Overview
30.2. 5.2. Products and Services
30.2. 5.3. Strategy
30.2.5.4. Financial Performance
31. Global Enzyme Inhibitor Market Competitive Benchmarking32. Global Enzyme Inhibitor Market Competitive Dashboard33. Key Mergers And Acquisitions In The Enzyme Inhibitor Market
34. Enzyme Inhibitor Market Future Outlook and Potential Analysis
34.1 Enzyme Inhibitor Market In 2028 - Countries Offering Most New Opportunities
34.2 Enzyme Inhibitor Market In 2028 - Segments Offering Most New Opportunities
34.3. Enzyme Inhibitor Market In 2028 - Growth Strategies
34.3.1 Market Trend Based Strategies
34.3.2 Competitor Strategies
35. Appendix
35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer

Executive Summary

Enzyme Inhibitor Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on enzyme inhibitor market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • All data from the report will also be delivered in an excel dashboard format.

Description:

Where is the largest and fastest growing market for enzyme inhibitor? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? This report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

Scope

  • Markets Covered: 1) By Type: Proton Pump Inhibitors (PPIs); Protease Inhibitors; Reverse Transcriptase Inhibitors; Aromatase Inhibitors; Kinase Inhibitors; Neuraminidase Inhibitors; Statins; Other Types 2) By Disease Indication: Chronic Obstructive Pulmonary Disorders; Cardiovascular Disease; Gastrointestinal Disorders; Arthritis; Inflammatory Diseases; Other Disease Indications 3) By Application: Chemotherapy; Antibiotics; Pesticides; Cardiovascular Treatments; Other Applications 4) By End User: Pharmaceutical; Biotechnology; Food and Beverage; Other End Users
  • Companies Mentioned: Abbott Laboratories; Amgen Inc.; AstraZeneca plc; Bayer AG; F. Hoffmann-La Roche AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • Amgen Inc.
  • AstraZeneca plc
  • Bayer AG
  • F. Hoffmann-La Roche AG
  • Pfizer Inc.
  • Ranbaxy Laboratories Limited
  • Takeda Pharmaceutical Company
  • Merck and Co. Inc.
  • Eli Lilly and Company
  • Bristol-Myers Squibb Company
  • Cipla USA Inc.
  • AbbVie Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Janssen Pharmaceuticals
  • Acellera Ltd.
  • Bioinfogate SL
  • BioSolveIT GmbH
  • Dassault Systèmes BIOVIA Corp.
  • ChemAxon Ltd.
  • Cheminformatics Tools and Services LLC
  • Cresset BioMolecular Discovery Ltd.
  • Dotmatics Limited
  • Enamine Ltd.
  • Forge Therapeutics Inc.
  • Inte:Ligand GmbH
  • LeadIT
  • Molecular Forecaster Inc.
  • Chemical Computing Group Inc.
  • OpenEye Scientific Software Inc.

Methodology

Loading
LOADING...